Malta vs United Arab Emirates: The number of people with susceptibility test result for rifampicin
Malta
27
in 2021
United Arab Emirates
23
in 2021
Malta rank
129th
United Arab Emirates rank
131st
The number of people with susceptibility test result for rifampicin over time
- Malta
- United Arab Emirates
How they compare
Malta currently reports 27 against 23 in United Arab Emirates, a difference of 4.
That makes Malta's figure about 1.2 times United Arab Emirates's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was United Arab Emirates ahead.
Malta ranks 129th and United Arab Emirates ranks 131st of 155 countries.
Across the 2 decades both report, Malta averaged higher in 1 and United Arab Emirates in 1.
Head to head by decade
| Decade | Malta | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 29 | 32 | 3 | United Arab Emirates |
| 2020s | 30.5 | 26 | 4.5 | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Malta or United Arab Emirates?
- Malta, at 27 against 23 in United Arab Emirates as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Malta and United Arab Emirates?
- 4, with Malta ahead.
- How many years of comparable data are there for Malta and United Arab Emirates?
- 5 years are reported by both, from 2017 to 2021.
- How do Malta and United Arab Emirates rank globally for the number of people with susceptibility test result for rifampicin?
- Malta ranks 129th and United Arab Emirates ranks 131st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.